Skåne University Hospital is a university hospital in Scania, Sweden. The hospital was founded in 2010 through the merger of the two university hospitals in Lund and Malmö.

During the past decade, Malmö Centre for Thrombosis and Haemostasis conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Malmö Centre for Thrombosis and Haemostasis" #1 collaborator was "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Rho, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Malmö Centre for Thrombosis and Haemostasis" are "Hemophilia A" (2 trials), "Alzheimer's Disease" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Malmö Centre for Thrombosis and Haemostasis" in a lesser frequency.

Most popular intervention types in "Malmö Centre for Thrombosis and Haemostasis" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Bendamustine" (1 trials), "Chlorambucil" (1 trials), "Cyclophosphamide" (1 trials), "FVIII concentrate" (1 trials) and "Fludarabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Malmö Centre for Thrombosis and Haemostasis" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Malmö Centre for Thrombosis and Haemostasis". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Malmö Centre for Thrombosis and Haemostasis, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Malmö Centre for Thrombosis and Haemostasis, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".